(Total Views: 243)
Posted On: 08/10/2022 7:25:57 PM
Post# of 1418
"Both the WP and RPP tests can be run on Provista’s state-of-the-art Tecan and 3D Med liquid handling automation systems that improve efficiency, safety and capacity, allowing Provista to currently perform up to 25,000 PCR tests per day. With nine (9) liquid handling systems currently onsite at Provista from former Todos PCR testing lab clients, the Company expects Provista to soon be able to run up to 50,000 PCR tests per day . Provista now has 7 Thermo Fisher PCR systems (2 QuantStudio 12k Flex, 2 QuantStudio 7 Flex, 3 QuantStudio 5) and 1 Biorad (CFX) system providing an ability to run over 2,400 patient samples at a time."
https://www.globenewswire.com/news-release/20...stics.html
50,000 x $100 = $5M x 365 = $1,825,000,000
$100 reimbursement per panel probably is very low, but at full capacity, Todos could be raking in the dough.
Covid, UTI, WP, RPP, MonkeyPox Long Covid panels/test.
I predict they will fill up capacity with the catalog of test they have and will end up buying more equipment and/or laps to expand capacity.
Oh then add in everything going on with 3CL Pharma, Videssa™ Breast Test, LymPro™: Alzheimer's Blood Test, etc.
Market Cap: 35.676M
WHEN the Cap is $3.5B, that is a stock that is $3 a share. I was thinking within a year, but the way things are going maybe sooner without the help of the pump crew who can go back and focus on other companies with no product, employee, revenue, etc.
Do your own DD and don't get it off a message board as there are fake stock analyst giving unsolicited investment advice.
https://todosmedical.com/rd-pipeline?hsLang=en
https://www.globenewswire.com/news-release/20...stics.html
50,000 x $100 = $5M x 365 = $1,825,000,000
$100 reimbursement per panel probably is very low, but at full capacity, Todos could be raking in the dough.
Covid, UTI, WP, RPP, MonkeyPox Long Covid panels/test.
I predict they will fill up capacity with the catalog of test they have and will end up buying more equipment and/or laps to expand capacity.
Oh then add in everything going on with 3CL Pharma, Videssa™ Breast Test, LymPro™: Alzheimer's Blood Test, etc.
Market Cap: 35.676M
WHEN the Cap is $3.5B, that is a stock that is $3 a share. I was thinking within a year, but the way things are going maybe sooner without the help of the pump crew who can go back and focus on other companies with no product, employee, revenue, etc.
Do your own DD and don't get it off a message board as there are fake stock analyst giving unsolicited investment advice.
https://todosmedical.com/rd-pipeline?hsLang=en
(2)
(0)Scroll down for more posts ▼
